SITUS JUDI MBL77 Options
Not all patients with CLL call for therapy. In spite of all modern developments, the iwCLL even now endorses watchful observation for individuals with asymptomatic disease.86 This recommendation is based on not less than two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR)